Therefore, for the first time in the world in GC and EGJC patients qualified for surgery, we have attempted to evaluate the HER2 gene copy number in cf-DNA in liquid biopsy in patients with GC and EGJC. The gene discussed is ERBB2; the disease is gastric cancer.